NR4A1 and neoplasm: It is worthy of note that patients with hormone receptor-positive tumours in this study received chemotherapy followed by sequential adjuvant tamoxifen, rather than primary concurrent chemoendocrine treatment used in earlier reports (Makris et al, 1998; Chang et al, 1999).